Emelie Barreby

Hypocholesterolemia in liver and cardiovascular disease: Friend or foe?

Findings indicate that clinical consequences are determined by the underlying biological mechanism rather than the degree of cholesterol lowering, and genetic testing may be considered in people with metabolic dysfunction-associated steatotic liver disease (MASLD) and hypocholesterolemia to clarify the mechanism, guide...